Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction

• Published in: Europace (London, England) England), 2023-12, Vol.26 (1)
• Main Authors: Xie, Zhonglei, Qi, Baozhen, Wang, Zimu, Li, Fuhai, Chen, Chaofeng, Li, Chaofu, Yuan, Shuai, Yao, Shun, Zhou, Jingmin, Ge, Junbo
• Format: Article
• Language: English
• Subjects: Ablation; Aged; Atrial Fibrillation - complications; Atrial Fibrillation - diagnosis; Atrial Fibrillation - surgery; Cardiac arrhythmia; Clinical Research; Cohort Studies; Congestive heart failure; Ejection fraction; Female; Fibrillation; Heart failure; Heart Failure - complications; Heart Failure - diagnosis; Heart Failure - surgery; Humans; Patients; Risk Factors; Stroke Volume - physiology; Tachycardia
• ISSN: 1099-5129; 1532-2092
• DOI: 10.1093/europace/euad363

Abstract Aims Patients with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have worse clinical outcomes than those with sinus rhythm (SR). We aim to investigate whether maintaining SR in patients with HFpEF through a strategy such as AF ablation would improve outcomes. Methods and results This is a cohort study that analysed 1034 patients (median age 69 [63–76] years, 46.2% [478/1034] female) with HFpEF and AF. Of these, 392 patients who underwent first-time AF ablation were assigned to the ablation group, and the remaining 642 patients, who received only medical therapy, were assigned to the no ablation group. The primary endpoint was a composite of all-cause death or rehospitalization for worsening heart failure. After a median follow-up of 39 months, the cumulative incidence of the primary endpoint was significantly lower in the ablation group compared to the no ablation group (adjusted hazard ratio [HR], 0.55 [95% CI, 0.37–0.82], P = 0.003) in the propensity score-matched model. Secondary endpoint analysis showed that the benefit of AF ablation was mainly driven by a reduction in rehospitalization for worsening heart failure (adjusted HR, 0.52 [95% CI, 0.34–0.80], P = 0.003). Patients in the ablation group showed a 33% relative decrease in atrial tachycardia/AF recurrence compared to the no ablation group (adjusted HR, 0.67 [95% CI, 0.54–0.84], P < 0.001). Conclusion Among patients with HFpEF and AF, the strategy of AF ablation to maintain SR was associated with a lower risk of the composite outcome of all-cause death or rehospitalization for worsening heart failure. Graphical Abstract Graphical Abstract AF, atrial fibrillation; HFpEF, heart failure with preserved ejection fraction.